These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2060091)

  • 1. Relation of arteriographically defined coronary artery disease to serum lipoprotein particles mapped with monoclonal antibodies.
    Fiévet C; Nuttens MC; Ducimetière P; Fruchart JC; Bertrand M; Salomez JL
    Circulation; 1991 Jul; 84(1):153-9. PubMed ID: 2060091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
    Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
    Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M; Kiasari AM; Mokhberi V
    Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parental history of early myocardial infarction is associated with decreased levels of lipoparticle AI in adolescents.
    Amouyel P; Isorez D; Bard JM; Goldman M; Lebel P; Zylberberg G; Fruchart JC
    Arterioscler Thromb; 1993 Nov; 13(11):1640-4. PubMed ID: 8218104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein particles LpA-I, LpA-I: A-II and LpB in coronary artery disease].
    Calvo C; Olmos A; Ulloa N; Bustos A; Toledo L; Durán D; Naveas R
    Rev Med Chil; 2000 Jan; 128(1):9-16. PubMed ID: 10883517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo.
    Bach-Ngohou K; Nazih H; Nazih-Sanderson F; Zaïr Y; Le Carrer D; Krempf M; Bard JM
    Int J Obes Relat Metab Disord; 2001 Dec; 25(12):1752-8. PubMed ID: 11781754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
    Heiba IM; DeMeester CA; Xia YR; Diep A; George VT; Amos CI; Srinivasan SR; Berenson GS; Elston RC; Lusis AJ
    Am J Med Genet; 1993 Nov; 47(6):875-83. PubMed ID: 8279486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins.
    Rasouli M; Kiasari AM
    Clin Chem Lab Med; 2006; 44(1):43-50. PubMed ID: 16375584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.
    van Capelleveen JC; Lee SR; Verbeek R; Kastelein JJP; Wareham NJ; Stroes ESG; Hovingh GK; Khaw KT; Boekholdt SM; Witztum JL; Tsimikas S
    J Clin Lipidol; 2018; 12(6):1493-1501.e11. PubMed ID: 30249512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease.
    Kukita H; Hiwada K; Kokubu T
    Atherosclerosis; 1984; 51(2-3):261-7. PubMed ID: 6430307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients.
    Haidari M; Moghadam M; Chinicar M; Ahmadieh A; Doosti M
    Clin Biochem; 2001 Mar; 34(2):149-55. PubMed ID: 11311225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipids, lipoproteins and apolipoproteins and sudden cardiac death.
    Tsuji A; Ikeda N; Nakamura T
    Int J Legal Med; 1999; 112(3):151-4. PubMed ID: 10335875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.
    Harano Y; Kageyama A; Nakao Y; Hara Y; Suzuki M; Sato A; Ikebuchi M; Shinozaki K; Tsushima M
    Diabetes; 1996 Jul; 45 Suppl 3():S31-4. PubMed ID: 8674886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
    Tornvall P; Båvenholm P; Landou C; de Faire U; Hamsten A
    Circulation; 1993 Nov; 88(5 Pt 1):2180-9. PubMed ID: 8222113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.